Benign or Malignant Cardiac Mass: Refining the Role of Cardiac Magnetic Resonance

Brian D. Hoit

DOI: https://doi.org/10.1161/circimaging.124.016574

2024-03-20

Circulation Cardiovascular Imaging

Abstract:Circulation: Cardiovascular Imaging, Volume 17, Issue 3, Page e016574, March 1, 2024.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems

What problem does this paper attempt to address?

Diagnostic mystery—a rare right ventricular cardiac hemangioma: a case report

Jingya Fan,Lei Guo,Peng Teng,Xiaoyi Dai,Qi Zheng,Shengjun Wu,Yiming Ni

DOI: https://doi.org/10.1186/s13019-021-01731-4

2021-01-01

Journal of Cardiothoracic Surgery

Abstract:Background Cardiac hemangiomas are rare in all kinds of benign cardiac tumors. Although cardiac hemangiomas affect all ages and may occur anywhere within the heart, right ventricular hemangiomas are extremely uncommon. Case presentation We report a 56-year-old woman presented with chest tightness and breath shortness for 3 months. Transthoracic echocardiography and coronary computed tomography angiography showed a mass located adjacent to the apex of the right ventricle but both failed to figure out where the mass originated from, remaining a diagnostic mystery preoperatively. The mass was removed successfully and the histopathological examination confirmed it was hemangioma. Conclusions Cardiac magnetic resonance should be the ultimate diagnostic tool of cardiac tumors. Surgical removal, associated with a low recurrence rate and long-term survival benefits, should be the first choice of therapy for cardiac hemangiomas.
Cardiovascular magnetic resonance imaging in suspected cardiac masses: histological correlation and clinical outcomes

C Dellino,M De Gaspari,P Garlini,M De Lazzari,A Cipriani,A Cecchetto,A Cecere,S Rizzo,G De Conti,R Motta,C Basso,S Iliceto,M Perazzolo Marra

DOI: https://doi.org/10.1093/ehjci/jead119.043

2023-06-01

European Heart Journal - Cardiovascular Imaging

Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Cardiac masses are an heterogeneous group of very rare formations, representing a major diagnostic challenge given the difficulty often encountered in assessing their nature through imaging examinations. Cardiac Magnetic Resonance (CMR) is a noninvasive key diagnostic tool providing anatomical, functional, and tissue characteristic information. However data validating this imaging approach are limited. Purpose 1) to analyze the clinical and CMR features of patients with benign and malignant tumors and thrombus; 2) to asses the diagnostic accuracy of CMR in comparison with the histologic examination;3) to evaluate the prognostic rule of clinical and CMR features in predicting the primary endpoint of all cause mortality. Methods 92 Patients undergoing CMR for suspected cardiac mass between June 2004 and January 2022 were retrospectively evaluated. Patients with no mass 8 (9%) or pseudomass 11 (12%) were excluded. Based on CMR images, masses were divided into benign tumor, malignant tumor, and thrombus. Clinical, CMR and histological data were collected. Results 73 patients (mean age: 62±15; 51% female) with masses were finally enrolled, 27 (37%) with a diagnosis at CMR of benign tumor, 22 (30%) with malignant tumor, and 24 (33%) with thrombus. Several clinical and CMR variables were significantly associated with one type of mass rather than another. Among clinical variables the history of malignancy and smoking were seen in patients with malignant tumors (p<0,002) while dyspnea and chest pain were significantly found in patients with thrombi (p<0,016). Among CMR features high size, infiltration, pericardial repeats, pericardial effusion, signal inhomogeneity, First Pass Perfusion (FPP) and Late Gadolinium Enhancement (LGE) were associated with malignant masses (p = 0.001), while reduced pre-contrast visualization, altered kinetics, low ejection fraction (EF) and long-TI were observed in thrombi (p = 0.001). CMR was accurate in 91.2% (31/34) of patients in comparison with the histological examination. Accuracy for benign tumors was 91.3% (AUC=0.913), for malignant tumors 94% (AUC=0.940) and for thrombi 83% (AUC=0.833). Patients diagnosed at CMR with thrombus had similar mortality as those with benign tumor (p = 0,678) while patients with malignant lesions had higher mortality (HR: 4.98 [95% CI: 1.11–22.2], p = 0,035). Regardless of diagnosis at CMR, age, tumor history, mass size, signal inhomogeneity, presence of FPP, pericardial effusion, and pericardial repeats were found to predict long-term mortality (p<0.017). Conclusions Although CMR has high diagnostic accuracy, histologic examination remains the diagnostic gold standard in determining the type of cardiac mass. In addition to playing a key role in the diagnostic process, CMR is also useful in predicting the clinical outcome of patients with cardiac masses.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Identification of Fibrosis in Hypertrophic Cardiomyopathy: a Radiomic Study on Cardiac Magnetic Resonance Cine Imaging.

Cailing Pu,Xi Hu,Sangying Lv,Yan Wu,Feidan Yu,Wenchao Zhu,Lingjie Zhang,Jingle Fei,Chengbin He,Xiaoli Ling,Fuyan Wang,Hongjie Hu

DOI: https://doi.org/10.1007/s00330-022-09217-0

IF: 7.034

2022-01-01

European Radiology

Abstract:OBJECTIVES:Hypertrophic cardiomyopathy (HCM) often requires repeated enhanced cardiac magnetic resonance (CMR) imaging to detect fibrosis. We aimed to develop a practical model based on cine imaging to help identify patients with high risk of fibrosis and screen out patients without fibrosis to avoid unnecessary injection of contrast.METHODS:A total of 273 patients with HCM were divided into training and test sets at a ratio of 7:3. Logistic regression analysis was used to find predictive image features to construct CMR model. Radiomic features were derived from the maximal wall thickness (MWT) slice and entire left ventricular (LV) myocardium. Extreme gradient boosting was used to build radiomic models. Integrated models were established by fusing image features and radiomic models. The model performance was validated in the test set and assessed by ROC and calibration curve and decision curve analysis (DCA).RESULTS:We established five prediction models, including CMR, R1 (based on the MWT slice), R2 (based on the entire LV myocardium), and two integrated models (ICMR+R1 and ICMR+R2). In the test set, ICMR+R2 model had an excellent AUC value (0.898), diagnostic accuracy (89.02%), sensitivity (92.54%), and F1 score (93.23%) in identifying patients with positive late gadolinium enhancement. The calibration plots and DCA indicated that ICMR+R2 model was well-calibrated and presented a better net benefit than other models.CONCLUSIONS:A predictive model that fused image and radiomic features from the entire LV myocardium had good diagnostic performance, robustness, and clinical utility.KEY POINTS:• Hypertrophic cardiomyopathy is prone to fibrosis, requiring patients to undergo repeated enhanced cardiac magnetic resonance imaging to detect fibrosis over their lifetime follow-up. • A predictive model based on the entire left ventricular myocardium outperformed a model based on a slice of the maximal wall thickness. • A predictive model that fused image and radiomic features from the entire left ventricular myocardium had excellent diagnostic performance, robustness, and clinical utility.
Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score

Pasquale Paolisso,Luca Bergamaschi,Francesco Angeli,Marta Belmonte,Alberto Foà,Lisa Canton,Damiano Fedele,Matteo Armillotta,Angelo Sansonetti,Francesca Bodega,Sara Amicone,Nicole Suma,Emanuele Gallinoro,Domenico Attinà,Fabio Niro,Paola Rucci,Elisa Gherbesi,Stefano Carugo,Saima Musthaq,Andrea Baggiano,Anna Giulia Pavon,Marco Guglielmo,Edoardo Conte,Daniele Andreini,Gianluca Pontone,Luigi Lovato,Carmine Pizzi

DOI: https://doi.org/10.1161/circimaging.123.016115

2024-03-20

Circulation Cardiovascular Imaging

Abstract:Circulation: Cardiovascular Imaging, Volume 17, Issue 3, Page e016115, March 1, 2024. BACKGROUND:Multimodality imaging is currently suggested for the noninvasive diagnosis of cardiac masses. The identification of cardiac masses' malignant nature is essential to guide proper treatment. We aimed to develop a cardiac magnetic resonance (CMR)-derived model including mass localization, morphology, and tissue characterization to predict malignancy (with histology as gold standard), to compare its accuracy versus the diagnostic echocardiographic mass score, and to evaluate its prognostic ability.METHODS:Observational cohort study of 167 consecutive patients undergoing comprehensive echocardiogram and CMR within 1-month time interval for suspected cardiac mass. A definitive diagnosis was achieved by histological examination or, in the case of cardiac thrombi, by histology or radiological resolution after adequate anticoagulation treatment. Logistic regression was performed to assess CMR-derived independent predictors of malignancy, which were included in a predictive model to derive the CMR mass score. Kaplan-Meier curves and Cox regression were used to investigate the prognostic ability of predictors.RESULTS:In CMR, mass morphological features (non-left localization, sessile, polylobate, inhomogeneity, infiltration, and pericardial effusion) and mass tissue characterization features (first-pass perfusion and heterogeneity enhancement) were independent predictors of malignancy. The CMR mass score (range, 0–8 and cutoff, ≥5), including sessile appearance, polylobate shape, infiltration, pericardial effusion, first-pass contrast perfusion, and heterogeneity enhancement, showed excellent accuracy in predicting malignancy (areas under the curve, 0.976 [95% CI, 0.96–0.99]), significantly higher than diagnostic echocardiographic mass score (areas under the curve, 0.932;P=0.040). The agreement between the diagnostic echocardiographic mass and CMR mass scores was good (κ=0.66). A CMR mass score of ≥5 predicted a higher risk of all-cause death (P<0.001; hazard ratio, 5.70) at follow-up.CONCLUSIONS:A CMR-derived model, including mass morphology and tissue characterization, showed excellent accuracy, superior to echocardiography, in predicting cardiac masses malignancy, with prognostic implications.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Approach to cardiac masses: Thinking inside and outside the box

Elia De Maria

DOI: https://doi.org/10.12998/wjcc.v12.i28.6132

2024-10-06

Abstract:In this editorial we comment on the article by Huffaker et al, published in the current issue of the World Journal of Clinical Cases. Cardiac masses encompass a broad range of lesions, potentially involving any cardiac structure, and they can be either neoplastic or non-neoplastic. Primitive cardiac tumors are rare, while metastases and pseudotumors are relatively common. Cardiac masses frequently pose significant diagnostic and therapeutic challenges. Multimodality imaging is fundamental for differential diagnosis, treatment, and surgical planning. In particular cardiac magnetic resonance (CMR) is currently the gold standard for noninvasive tissue characterization. CMR allows evaluation of the relationship between the tumor and adjacent structures, detection of the degree of infiltration or expansion of the mass, and prediction of the possible malignancy of a mass with a high accuracy. Different flow charts of diagnostic work-up have been proposed, based on clinical, laboratory and imaging findings, with the aim of helping physicians approach the problem in a pragmatic way ("thinking inside the box"). However, the clinical complexity of cancer patients, in particular those with rare syndromes, requires a multidisciplinary approach and an open mind to go beyond flow charts and diagnostic algorithms, in other words the ability to "think outside the box".
Cardiac Tumors: Clinical Presentation, Diagnosis, and Management

Timothy J Poterucha,Jonathan Kochav,Daniel S O'Connor,Gregg F Rosner

DOI: https://doi.org/10.1007/s11864-019-0662-1

2019-06-27

Abstract:Cardiac masses and tumors are a heterogenous group of disorders and include primary tumors (both benign and malignant), metastatic disease, and numerous masquerades such as thrombus. Clinical presentation ranges from incidental discovery on imaging tests ordered for other reasons to life-threatening presentations such as cardiac tamponade, arrhythmia, obstruction, and systemic embolization. Of the available imaging modalities, cardiac MRI is generally the most useful for assessment and helps to delineate the relevant anatomy. Due to the technical difficulties and risk of biopsy of cardiac masses, a presumptive diagnosis is typically made using imaging techniques with surgery serving both a diagnostic and curative role. Because these conditions can vary widely in their management, we recommend early involvement of a multidisciplinary group which should include a cardiologist, cardiac surgeon, and oncologist.
Evaluation of cardiac masses by CMR-strengths and pitfalls: a tertiary center experience

Roja Tumma,Wei Dong,Jing Wang,Harold Litt,Yuchi Han

DOI: https://doi.org/10.1007/s10554-016-0845-9

Abstract:Cardiovascular magnetic resonance (CMR) imaging is often considered the reference method to assess cardiac tumors. However, little data exists concerning the effectiveness of CMR for the accurate diagnosis of cardiac masses. We sought to understand the diagnostic value of CMR for evaluation of suspected cardiac mass. A total of 249 consecutive CMR cases performed at a single center from January 2005 to June 2013 for evaluation of masses found on echocardiography or computed tomography (CT) were included. All the clinical data and imaging features of these patients were retrospectively reviewed and medical records were verified for follow up care. More than half of the patients referred for evaluation of masses found at echocardiography or CT were found to have no evidence of mass by CMR. CMR correctly differentiated between thrombus and myxoma in 88.4 % cases. Malignant masses were accurately diagnosed on CMR. However, CMR missed or misdiagnosed a few cases of benign masses. Diagnosing cardiac masses remains an important use for imaging, despite technical difficulties with current imaging modalities. CMR can play a key role in confirming presence or absence of a mass. Additionally, in the presence of a mass, CMR can provide accurate differentiation of pseudomasses, benign and malignant masses. However, the limitations of CMR must be recognized.
Cardiac Tumors: JACC CardioOncology State-of-the-Art Review

Sara Tyebally,Daniel Chen,Sanjeev Bhattacharyya,Abdallah Mughrabi,Zeeshan Hussain,Charlotte Manisty,Mark Westwood,Arjun K Ghosh,Avirup Guha

DOI: https://doi.org/10.1016/j.jaccao.2020.05.009

2020-06-16

Abstract:Cardiac masses are rare, but remain an important component of cardio-oncology practice. These include benign tumors, malignant tumors (primary and secondary) and tumor-like conditions (e.g., thrombus, Lambl's excrescences, and pericardial cyst). The advent of multimodality imaging has enabled identification of the etiology of cardiac masses in many cases, especially in conjunction with information from clinical settings. This paper provides a comprehensive review of the epidemiology, clinical presentation, imaging, diagnosis, management, and outcomes of cardiac masses.
Additional value of CMR parametric mapping in tissue characterization of common benign pediatric cardiac tumors

Paolo Ciliberti,Veronica Bordonaro,Davide Curione,Alessio Perazzolo,Paolo Ciancarella,Teresa Santangelo,Carmela Napolitano,Luigi Natale,Lorenzo Galletti,Aurelio Secinaro

DOI: https://doi.org/10.1093/ehjci/jeae187

2024-07-25

Abstract:Background: Cardiac Magnetic Resonance (CMR) parametric mapping is underexplored in cardiac tumors. Objectives: To evaluate the contribution of mapping sequences on the characterization of pediatric tumors. Methods: All pediatric patients referred for cardiac tumors at Bambino Gesù Children's Hospital from June 2017 to November 2023, who underwent CMR with mapping sequences, were included. The diagnosis of tumor type was performed according to signal characteristics on different sequences. Mass parametric mapping for each subtype and interobserver variability was assessed. Results: Sixteen patients were enrolled. The mean age at CMR was 7 ± 5 years. "Traditional" mass-type assessment diagnosed hemangioma (Group A) in 3 patients (19%), fibroma (Group B) in 4 patients (25%), rhabdomyoma (Group C) in 6 patients (37%), and lipoma (Group D) in 3 patients (19%). The ANOVA analysis revealed significant differences in mass native T1 and mass extracellular volume (ECV) values among the four subgroups (p<0.001 for both comparisons). The mean native T1 and ECV values were respectively 1465 ± 158 msec and 54 ± 4% for Group A, 860 ± 118 msec and 93 ± 4% for Group B, 1007 ± 57 msec and 23 ± 5% for Group C, and 215 ± 13 msec and 0 ± 0% for Group D. Conclusions: Mass mapping analysis is feasible and reproducible in children. ECV values provide the most accurate differentiation. Mass ECV consistently resembles normal myocardium in rhabdomyoma, is extremely high (approaching 100%) in fibroma, equals to zero in lipoma, and matches blood pool ECV (1-Hct) in hemangioma.
Bridging the gap in cardiac mass diagnosis: Advanced imaging, genetic associations, and biomarkers

Yi-Hao Loh,Xu-Lin Hong

DOI: https://doi.org/10.12998/wjcc.v12.i22.4859

2024-08-06

World Journal of Clinical Cases

Abstract:In this editorial we comment on the article by Huffaker et al published in a recent issue of the World Journal of Clinical Cases . We focus on cardiac tumors linked to genetic syndromes and the differential diagnosis of cardiac masses. As cardiomyocytes lack the ability to actively divide, primary cardiac tumors are extremely rare across all ethnicities and age groups. Once they occur, these tumors are often associated with genetic mutations and, occasionally, genetic syndromes. This underscores the importance of considering genetic mutations and syndromes when encountering these cases. The more common growths in the heart are thrombi and vegetations, which can mimic tumors, further making the differential diagnosis challenging. Among the imaging techniques, contrast-enhanced cardiac magnetic resonance imaging has the highest sensitivity for differential diagnosis. To aid in the differential diagnosis of cardiac masses, especially thrombi, appropriate utilization of biomarkers (i.e. D-dimer level) may provide pivotal clinical implications. Employing a multidisciplinary approach that integrates personal history, epidemiological insights, imaging findings, genetic markers, and biomarkers is therefore critical in the diagnostic process of cardiac masses.

medicine, general & internal
Evaluation of Cardiac Involvement with Mediastinal Lymphoma: the Role of Innovative Integrated Cardiovascular Imaging

Mark Goldman,Robert Matthews,Hong Meng,Thomas Bilfinger,Smadar Kort

DOI: https://doi.org/10.1111/j.1540-8175.2012.01746.x

2012-01-01

Echocardiography

Abstract:A 73‐year‐old woman presented in right heart failure. Computed tomography of the chest revealed a 3 cm × 5 cm anterior mediastinal mass. Contrast‐enhanced two‐dimensional transthoracic echocardiography, cardiac magnetic resonance imaging (MRI), positron emission tomography (PET), and MRI–PET fusion demonstrated invasion of the pericardium and right heart by the tumor. Mediastinal biopsy revealed high‐grade diffuse large B‐cell lymphoma, which responded to chemotherapy. The role of each modality in this case was discussed in the manuscript. In conclusion, the integration of multiple imaging modalities is extremely useful in the characterization, localization, diagnosis and treatment of an unusual cardiac mass.
Collection of cardiac masses. Up‐to‐date echocardiography and cardiac MRI tools

Roberto Baltodano‐Arellano,Luis Falcón‐Quispe,Kelly Cupe‐Chacalcaje,Gabriela Meléndez‐Ramírez,Angela Cachicatari‐Beltran,Sergio Patrón‐Chi,Lindsay Benites‐Yshpilco,Aloha Meave‐González,William Anicama‐Lima,Silvia Jiménez Becerra,Dante Urdanivia‐Ruiz,José Antonio Arias‐Godínez,Paol Rojas,Josh Moscoso,Gerald Levano‐Pachas

DOI: https://doi.org/10.1111/echo.15757

2024-02-04

Echocardiography

Abstract:Heart masses, including tumors (primary and secondary) and pseudotumor (cysts and thrombus), are rare entities, but of increasing interest in cardiac imaging areas. The clinical manifestations are related to the intracardiac effect of mass, embolization, and systemic symptoms in the case of tumors; however, some of them are detected incidentally. Nowadays, imaging techniques and the advancement of their tools perform the morphological, functional, and tissue characterization of the masses, and additionally know the anatomical relationships, which are crucial factors for the treatment and surgical planning.

cardiac & cardiovascular systems
An Unusual Case of Cardiac Mass: A Multimodal Approach in Diagnosis and Treatment

Ljiljana Rankovic-Nicic,Milica Dragicevic-Antonic,Zelimir Antonic,Vladimir Mihajlovic,Masa Petrovic,Tjasa Ivosevic,Gordana Stamenkovic,Svetislav Pelemis,Milovan Bojic

DOI: https://doi.org/10.3390/healthcare12101009

2024-05-15

Health Care

Abstract:Diagnosing intracardiac masses poses a complex, multimodal challenge. We present the case of a 72-year-old woman with a history of rheumatic fever leading to mitral stenosis and a previous mitral valve commissurotomy who reported fatigue, weakness, and palpitations over the past three months. Echocardiography revealed a tumor (53 × 40 mm) in the enlarged left atrium, attached by a wide base to the left atrium wall, exhibiting variable densities. Computerized tomography identified a heterodense mass (53 × 46 × 37 mm) with similar attachments. Angiography showed two branches from the circumflex artery intricately associated with the mass. Despite unsuccessful embolization of the mass' blood supply, surgical intervention including mitral valve replacement, tricuspid valve annuloplasty, and tumor removal was pursued. Pathohistological analysis confirmed the mass as a thrombus. During the postoperative follow-up, the patient presented with no complaints. Follow-up echocardiography indicated the normal function of the mechanical mitral valve prosthesis and the absence of intracardiac masses. While it remains unknown whether this neovascularization is specific to patients with severe mitral valve disease, this case highlights the diagnostic challenges of differentiating between thrombi and tumors in the context of mitral valve disease. It illustrates the critical role of multimodal imaging in elucidating the anatomical and functional relationships within the heart, thereby guiding accurate diagnosis and effective treatment.

health care sciences & services,health policy & services
Overall approaches to cardiac tumors: Still an unsolved enigma?

Pasquale Totaro,Martina Musto

DOI: https://doi.org/10.12998/wjcc.v12.i19.3654

2024-07-06

World Journal of Clinical Cases

Abstract:Cardiac tumors are neoplasms involving heart structures at any level, meaning the myocardium, valves, and cardiac chambers. When considering cardiac masses, it is not uncommon for surgeons to be surprised when they diagnose one. The real incidence of this complex group of diseases has been explored only after cardiac diagnostic tools became more appropriate. Despite differential diagnosis being relevant, surgical indication is usually requested for all malignant cardiac tumors and also for many types of benign tumors. The development of cardiac imaging techniques, therefore, has been the key point for a better understanding of the history of cardiac tumors and especially of the relevance of surgical indication in such conditions. Systematic and combined applications of echocardiography, cardiac computed tomography and magnetic resonance allow in the majority of case a clear definition of the nature of a newly discovered cardiac mass. The presence of a Li-Fraumeni syndrome seems to be the trigger aspect in accelerating the propensity of developing a cardiac tumor. Despite the revolutionary usefulness of the cardiac imaging techniques available, it is still considered a hazard to diagnose a malignant cardiac mass just with radiological imaging; the mainstay of the final diagnosis stands in surgical excision of the mass and histopathological report.

medicine, general & internal
Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy

Deborah H. Kwon,Shuaiqi Huang,Mustafa Turkmani,Donna Salam,Danah Al-Dieri,Tom Kai Ming Wang,Samir R. Kapadia,Amar Krishnaswamy,Marc Gillinov,Lars G. Svensson,Richard A. Grimm,W.H. Wilson Tang,David Chen,Christopher T. Nguyen,Xiaofeng Wang

DOI: https://doi.org/10.1161/circimaging.123.016006

2024-04-17

Circulation Cardiovascular Imaging

Abstract:Circulation: Cardiovascular Imaging, Volume 17, Issue 4, Page e016006, April 1, 2024. BACKGROUND:Significant controversy continues to confound patient selection and referral for revascularization and mitral valve intervention in patients with ischemic cardiomyopathy (ICM). Cardiac magnetic resonance (CMR) enables comprehensive phenotyping with gold-standard tissue characterization and volumetric/functional measures. Therefore, we sought to determine the impact of CMR-enriched phenomapping patients with ICM to identify differential outcomes following surgical revascularization and surgical mitral valve intervention (sMVi).METHODS:Consecutive patients with ICM referred for CMR between 2002 and 2017 were evaluated. Latent class analysis was performed to identify phenotypes enriched by comprehensive CMR assessment. The primary end point was death, heart transplant, or left ventricular assist device implantation. A multivariable Cox survival model was developed to determine the association of phenogroups with overall survival. Subgroup analysis was performed to assess the presence of differential response to post-magnetic resonance imaging procedural interventions.RESULTS:A total of 787 patients were evaluated (63.0±11.2 years, 24.8% women), with 464 primary events. Subsequent surgical revascularization and sMVi occurred in 380 (48.3%) and 157 (19.9%) patients, respectively. Latent class analysis identified 3 distinct clusters of patients, which demonstrated significant differences in overall outcome (P<0.001). Latent class analysis identified differential survival benefit of revascularization in patients as well as patients who underwent revascularization with sMVi, based on phenogroup classification, with phenogroup 3 deriving the most survival benefit from revascularization and revascularization with sMVi (hazard ratio, 0.61 [0.43–0.88];P=0.0081).CONCLUSIONS:CMR-enriched unsupervised phenomapping identified distinct phenogroups, which were associated with significant differential survival benefit following surgical revascularization and sMVi in patients with ICM. Phenomapping provides a novel approach for patient selection, which may enable personalized therapeutic decision-making for patients with ICM.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions

Alessandra Scatteia,Santo Dellegrottaglie

DOI: https://doi.org/10.1093/eurheartjsupp/suad007

2023-04-26

European Heart Journal Supplements

Abstract:Abstract Ischemic cardiomyopathy is a significant cause of mortality and morbidity, with peculiar needs for accurate diagnostic and prognostic characterization. Cardiac magnetic resonance (CMR) can help to satisfy these requirements by allowing a comprehensive evaluation of myocardial function, perfusion and tissue composition, with a demonstrated utility in guiding clinical management of patients with known or suspected ischemic cardiomyopathy. When compared with alternative non-invasive imaging modalities, such as stress echocardiography and nuclear techniques, CMR is able to provide accurate (function and perfusion) or peculiar (tissue characterization) information on cardiac pathophysiology, while avoiding exposition to ionizing radiations and overcoming limitations related to the quality of the imaging window. In particular, stress perfusion CMR showed to be accurate, safe, cost-effective, and clinically valuable as a non-invasive test for detecting severity and distribution of myocardial ischemia. In many circumstances, however, local availability of the technique, together with procedural costs, and scanning and post-processing time duration still limit the use of CMR in clinical routine. In the current review, we focused on clinical applications of CMR in ischemic cardiomyopathy. The consolidated role of the technique is described by illustrating both standard and advanced sequences that constitute the current body of a dedicated CMR examination. Ongoing developments and potential future diagnostic and prognostic applications of CMR when assessing ischemic cardiomyopathy are also discussed, with a focus on artificial intelligence-based implementations proposed for refining the efficiency of CMR analysis and reporting.

cardiac & cardiovascular systems
Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Fahad Alajmi,Mehima Kang,James Dundas,Alexander Haenel,Jeremy Parker,Philipp Blanke,Fionn Coghlan,John King Khoo,Abdulaziz A. Bin Zaid,Amrit Singh,Bobby Heydari,Darwin Yeung,Thomas M. Roston,Kevin Ong,Jonathon Leipsic,Zachary Laksman

DOI: https://doi.org/10.3390/life14020200

2024-01-31

Life

Abstract:Hypertrophic cardiomyopathy (HCM) is a common genetic disorder with a well described risk of sudden cardiac death; however, risk stratification has remained a challenge. Recently, novel parameters in cardiac magnetic resonance imaging (CMR) have shown promise in helping to improve upon current risk stratification paradigms. In this manuscript, we have reviewed novel CMR risk markers and their utility in HCM. The results of the review showed that T1, extracellular volume, CMR feature tracking, and other miscellaneous novel CMR variables have the potential to improve sudden death risk stratification and may have additional roles in diagnosis and prognosis. The strengths and weaknesses of these imaging techniques, and their potential utility and implementation in HCM risk stratification are discussed.

biology
Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist

Jayanth Ranjit Arnold,Gerry P McCann

DOI: https://doi.org/10.1136/heartjnl-2019-314856

IF: 5.7

Heart

Abstract:Cardiovascular magnetic resonance (CMR) is a rapidly evolving non-invasive imaging modality offering comprehensive, multiparametric assessment of cardiac structure and function in a variety of clinical situations. Cine imaging with CMR is the gold standard non-invasive imaging technique for the quantification of ventricular volumes and systolic function. It also affords superior visualisation of apical and right ventricular morphological abnormalities. In coronary artery disease, CMR stress perfusion imaging identifies functionally significant coronary artery disease with high sensitivity and specificity, and international guidelines recommend CMR perfusion imaging in patients with chest pain at intermediate-high risk of coronary disease. Late gadolinium enhancement (LGE) imaging is the most sensitive imaging technique for identifying infarction/viability. In non-ischaemic cardiomyopathy, LGE imaging plays vital diagnostic and prognostic roles in a number of cardiomyopathies (eg, hypertrophic and dilated cardiomyopathies, and amyloidosis). In vivo tissue characterisation with CMR enables the identification of oedema/inflammation in acute coronary syndromes/myocarditis and the diagnosis of chronic fibrotic conditions (eg, in hypertrophic and dilated cardiomyopathy, aortic stenosis and amyloidosis). CMR T2* imaging uniquely offers non-invasive assessment of iron overload states, facilitating diagnosis and management. A multiparametric CMR approach also enables differentiation of cardiac masses/tumours and is a useful adjunct to echocardiography in the assessment of valve disease. The emergence of automated, inline, quantitative methodologies will expand the scope of CMR and reduce its cost in forthcoming years.
Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies

Nicola Galea,Gesualdo Polizzi,Marco Gatti,Giulia Cundari,Michele Figuera,Riccardo Faletti

DOI: https://doi.org/10.1007/s11547-020-01287-8

2020-09-24

La radiologia medica

Abstract:Abstract The restrictive cardiomyopathies constitute a heterogeneous group of myocardial diseases with a different pathogenesis and overlapping clinical presentations. Diagnosing them frequently poses a challenge. Echocardiography, electrocardiograms and laboratory tests may show non-specific changes. In this context, cardiac magnetic resonance (CMR) may play a crucial role in defining the diagnosis and guiding treatments, by offering a robust myocardial characterization based on the inherent magnetic properties of abnormal tissues, thus limiting the use of endomyocardial biopsy. In this review article, we explore the role of CMR in the assessment of a wide range of myocardial diseases causing restrictive patterns, from iron overload to cardiac amyloidosis, endomyocardial fibrosis or radiation-induced heart disease. Here, we emphasize the incremental value of novel relaxometric techniques such as T1 and T2 mapping, which may recognize different storage diseases based on the intrinsic magnetic properties of the accumulating metabolites, with or without the use of gadolinium-based contrast agents. We illustrate the importance of these CMR techniques and their great support when contrast media administration is contraindicated. Finally, we describe the useful role of cardiac computed tomography for diagnosis and management of restrictive cardiomyopathies when CMR is contraindicated.

radiology, nuclear medicine & medical imaging
Role of Cardiac Magnetic Resonance in Inflammatory and Infiltrative Cardiomyopathies: A Narrative Review

Davide Marchetti,Federica Buzzi,Riccardo Di Febo,Sara Modugno,Matteo Schillaci,Pasquale Paolisso,Marco Doldi,Eleonora Melotti,Angelo Ratti,Andrea Provera,Gianluca Guarnieri,Riccardo Terzi,Michele Gallazzi,Edoardo Conte,Daniele Andreini

DOI: https://doi.org/10.3390/jcm13164733

2024-08-12

Abstract:Cardiac magnetic resonance (CMR) has acquired a pivotal role in modern cardiology. It represents the gold standard for biventricular volume and systolic function assessment. Moreover, CMR allows for non-invasive myocardial tissue evaluation, highlighting tissue edema, fibrosis, fibro-fatty infiltration and iron overload. This manuscript aims to review the impact of CMR in the main inflammatory and infiltrative cardiomyopathies, providing details on specific imaging patterns and insights regarding the most relevant trials in the setting.

Benign or Malignant Cardiac Mass: Refining the Role of Cardiac Magnetic Resonance

Diagnostic mystery—a rare right ventricular cardiac hemangioma: a case report

Cardiovascular magnetic resonance imaging in suspected cardiac masses: histological correlation and clinical outcomes

Identification of Fibrosis in Hypertrophic Cardiomyopathy: a Radiomic Study on Cardiac Magnetic Resonance Cine Imaging.

Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score

Approach to cardiac masses: Thinking inside and outside the box

Cardiac Tumors: Clinical Presentation, Diagnosis, and Management

Evaluation of cardiac masses by CMR-strengths and pitfalls: a tertiary center experience

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review

Additional value of CMR parametric mapping in tissue characterization of common benign pediatric cardiac tumors

Bridging the gap in cardiac mass diagnosis: Advanced imaging, genetic associations, and biomarkers

Evaluation of Cardiac Involvement with Mediastinal Lymphoma: the Role of Innovative Integrated Cardiovascular Imaging

Collection of cardiac masses. Up‐to‐date echocardiography and cardiac MRI tools

An Unusual Case of Cardiac Mass: A Multimodal Approach in Diagnosis and Treatment

Overall approaches to cardiac tumors: Still an unsolved enigma?

Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy

Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions

Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist

Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies

Role of Cardiac Magnetic Resonance in Inflammatory and Infiltrative Cardiomyopathies: A Narrative Review